Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 22 Jul, 01:30 am
Morgan Stanley downgraded Intuit to "Equalweight" with a $335.00 price target, signaling a cautious outlook despite potential upside. Intuit faces challenges in its do-it-yourself (DIY) tax business , losing lower-income customers due to pricing, and plans to introduce more compe
Lexington Realty Trust (NYSE: LXP) , a prominent industrial real estate investment trust (REIT), owns a vast portfolio of modern warehouses and logistics properties across the U.S. The company's stock was downgraded by Citigroup (NYSE: C) from "Outperform" to "Perform" following
ServisFirst Bancshares (NYSE: SFBS) reported earnings per share (EPS) of $1.57 , meeting analyst estimates and marking a significant 40% increase year-over-year. The regional bank achieved robust revenues of $168.53 million , surpassing consensus forecasts and demonstrating 19.8%
Calix (NYSE: CALX) reported an impressive earnings per share (EPS) of $0.47 , significantly beating the consensus estimate of $0.40 by 17.50% . The company demonstrated strong revenue performance , posting $293.33 million for the quarter, surpassing estimates by 1.20% and showing
Steel Dynamics (NASDAQ:STLD) reported an impressive earnings per share (EPS) of $3.69 , significantly surpassing analyst estimates for Q2 2026. The company achieved robust total sales of $6.1 billion , exceeding expectations and driven by strong steel pricing . Operational streng
Ryanair (NASDAQ: RYAAY) missed Q2 analyst forecasts for both earnings per share and revenue, indicating a challenging quarter for the low-cost airline. The company experienced a significant profit decline of 34% , primarily driven by a doubling in unhedged fuel prices and a 6% de
Analyst firm BMO Capital has set a new, higher price target for Axsome Therapeutics, reflecting strong confidence and significant growth potential for the stock. The U.S. Food and Drug Administration (FDA) has accepted Axsome's New Drug Application for AXS-12, a key regulatory mi
Goldman Sachs (NYSE:GS) received an upgrade to Hold from HSBC, signaling a more neutral analyst outlook for the investment banking giant. The global financial institution reported record second-quarter results, surpassing both revenue and earnings expectations due to strong inves
AMC Entertainment Holdings (NYSE: AMC) reported a surprise profit with adjusted earnings per share (EPS) of $0.14 , significantly beating analyst expectations. The company achieved record revenue of $1.60 billion , marking a 14.2% increase year-over-year. Operational improvements
Insmed (NASDAQ: INSM) received an "Outperform" rating and a $192.00 price target from BMO Capital, indicating a potential 79.41% upside. The company's PAH treatment, TPIP, showed positive 12-month clinical data with sustained patient improvement and a strong safety profile. Insti
Analyst Confidence: Financial firm BMO Capital initiated "Outperform" coverage on Axsome Therapeutics, citing strong drug pipeline progress and market potential. Regulatory Milestones: The U.S. Food and Drug Administration (FDA) accepted Axsome Therapeutics' New Drug Application
Analysts project Novartis (NYSE: NVS) to report Q2 earnings per share (EPS) of $2.17 and revenue of $14.07 billion , following a challenging Q1 impacted by patent expirations. Despite a first-quarter decline, Novartis demonstrated strong cash generation, reporting a stable free c
BMO Capital initiated an "Outperform" rating on Insmed (NASDAQ:INSM) , citing a positive outlook for the biopharmaceutical company. Insmed's drug, treprostinil palmitil inhalation powder (TPIP), demonstrated positive 12-month clinical data, showing sustained patient improvement a
Domino's Pizza (NYSE: DPZ) reported mixed second-quarter results , with earnings per share missing estimates but revenue exceeding expectations. The revenue beat was driven by strong supply chain revenues and robust order growth across delivery and carryout channels , showcasing
KeyCorp (NYSE: KEY) Earnings Preview: Regional Bank Anticipates Strong NII Growth Analysts project KeyCorp's EPS to reach $0.42 , marking a 20% year-over-year increase, with total revenue expected to hit $1.97 billion , an 8% rise. Net interest income (NII) is a key growth driver
Vision Marine Technologies (NASDAQ: VEEE) experienced a sharp decline following a strategic shift from boat manufacturing to a mining project, creating investor uncertainty. Karyopharm Therapeutics Inc. (NASDAQ: KPTI) shares fell amidst concerns over potential share dilution from
Zhengye Biotechnology surged over 1047% , regaining Nasdaq compliance after a minimum bid price notice. Advanced Biomed Inc. and Axe Compute Inc. saw notable gains following a reverse stock split and Russell Microcap® Index inclusion, respectively. Leveraged ETFs tracking IRE
Strong Revenue Growth Expected: Northrop Grumman is projected to report approximately $10.78 billion in revenue, a 4.1% increase year-over-year, driven by robust demand in the defense sector. EPS Decline Anticipated: Despite revenue growth, analysts estimate an earnings per share
Headlines provided by Investing.com